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Background: Behavioral risks such as age at first sexual intercourse, number of sexual partners and partner’s sexual
behavior are associated with an increased risk of HPV infection, persistence of the infection and the development
of neoplastic precursor lesions. The objective of this study was to evaluate the risk factors associated with HPV
positivity and with a diagnosis of cervical neoplasia in women referred with an abnormal cervical smear.
Methods: This study evaluated a series of 198 women referred with an abnormal cervical smear. Risk factors for
HPV infection were investigated using a questionnaire. All cervical specimens were tested for 27 HPV genotypes
using the Roche polymerase chain reaction reverse line blot assay.
Results: The overall prevalence of HPV was 87 %. First sexual intercourse before 16 years of age was significantly
associated with a positive HPV test (OR 4.41; 95 %CI: 1.20 − 19.33; p = 0.01). A significant association was also found
between this risk factor and CIN 1 lesions or worse (OR 2.2; 95 %CI 0.94 − 5.08; p = 0.03).
Conclusions: The age at which a woman begins to be sexually active is associated with HPV infection and with a
diagnosis of cervical neoplasia.
Keywords: Human papillomavirus, Risk factors, Abnormal cervical smearBackground
Human papillomavirus (HPV) infection of the genital tract
is thought to be the most common sexually transmitted
virus. The prevalence of this infection is age-dependent
and is higher in women between 15 and 25 years of age.
The decrease in the rate of HPV infection with increasing
age likely results from some combination of decreased
HPV exposure, the self-limiting nature of most infections
and a resistance to re-infection [1, 2].
Persistent infection with human papillomavirus (HPV)
is a prerequisite for cervical cancer and its precursor le-
sions [3, 4]. The higher risk of HPV infection among
younger women has been related to a lack of adaptive
immune responses and/or the relatively larger area of
cervical epithelium undergoing squamous metaplasia [5].* Correspondence: shrabelo@ufg.br
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adults in that it has greater areas of immaturity, described
as a predominance of columnar and metaplastic epithe-
lium. An example of the fragility of this area is the com-
mon presence of blood when cervical smears are obtained
in adolescents who have large areas of ectopy [6, 7].
Behavioral risks such as age at first sexual intercourse,
the number of sexual partners and the partner’s sexual
behavior are associated with an increased risk of HPV
infection [8, 9]. Studies have shown that higher preva-
lence rates of high-risk HPV infection and also a higher
proportion of women with multiple high-risk infections
may be related to sexual behavior, social class, high par-
ity, lack of barrier contraceptive protection and long-
term use of oral contraceptives [10].
Co-factors that would act by affecting the way in which
HPV is acquired, its persistence and development, as well
as its progression to neoplastic lesions, are common [11].
In addition to persistent HPV infection with high-risk ge-
notypes, multiple sexual partners, overall lifetime numbere is distributed under the terms of the Creative Commons Attribution 4.0
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smoking are risk factors associated with the development
of cervical cancer [7, 5, 12].
Therefore, the objective of this study was to evaluate
the risk factors associated with HPV infection and with
neoplastic diagnoses in women referred with an abnor-
mal cervical smear.
Methods
Specimens
This study was conducted at a colposcopy referral clinic in
Goiânia, central Brazil. Between January 2006 and March
2009, a series of 198 women with an abnormal cervical
smear were included. The study protocol was approved by
the Internal Review Board of the Pontifical Catholic Univer-
sity of Goiás with the registration CEP 003/05.
All the participants answered a complete standardized
questionnaire concerning age, smoking, age at first sex-
ual intercourse, number of lifetime sexual partners, oral
contraceptive use and number of pregnancies. Exclusion
criteria consisted of pregnancy and clinical signs of im-
munosuppression. The study protocol was approved by
the institute’s internal review board and all patients
signed an informed consent form.
At colposcopy, a cervical sample was taken for a sec-
ond conventional smear using a cervical brush, and the
residual material was rinsed with and then stored in
1.0 mL Universal Collection Medium (QIAGEN Sample
& Assay Technologies, São Paulo, Brazil) for HPV DNA
testing. Biopsies were taken from any colposcopically ab-
normal area. Women with a suspicious image penetrat-
ing the cervical canal and those in whom colposcopy
was unsatisfactory and a second cervical smear was ab-
normal were submitted to cervical conization. Women
with invasive carcinomas were treated in compliance
with the appropriate clinical guidelines. When a woman
was submitted to more than one histological examin-
ation, the most severe diagnosis was the one taken into
consideration.
During the study period, 193 biopsies were performed
and analyzed according to the criteria defined by the
World Health Organization, being classified as normal/
cervicitis, CIN 1, CIN 2, CIN 3, invasive squamous cell
carcinoma (SCC) or invasive adenocarcinoma. The
remaining 5 women in the study tested negative at col-
poscopy and negative in their repeat cervical smear;
therefore, the final diagnosis in these cases was negative
for neoplasia. For the purposes of analysis, they were
classified together with the women with normal results
at histology or those with a finding of cervicitis. These 5
women were scheduled to return for follow-up visits
every 3 months, and at the cut-off date for this analysis
the duration of follow up in these cases ranged from
3 months to 2 years.Sample processing, DNA extraction and HPV-DNA testing
The samples were processed as previously described [13].
HPV amplification and genotyping was carried out by
using the Roche polymerase chain reaction (PCR)-based
Linear Array® HPV genotyping test (Roche Molecular
Systems, Branchburg, NJ, USA). HPV DNA was amplified
using the L1 consensus biotinylated PGMY09/PGMY11
primer set in a thermal cycler at 95 °C for 13 min,
followed by desnaturation for 1 min at 95 °C, annealing
for 1 min at 55 °C, and extension at 72 °C for 1 min for a
total of 40 cycles. Amplification was followed by a 5-min
terminal extension step at 72 °C. Biotinylated GH20 and
PC04 primers to the β-globin gene were used as amplifica-
tion control. PCR products were denatured in 1.6 %
sodium hydroxide (NaOH) and hybridized to an immobi-
lized probe array containing probes for β-globin at 2
concentrations plus 37 HPV genotypes. One of groups
included the HPV types 16, 18, 26, 31, 33, 35, 39, 45,
51, 52, 53, 56, 58, 59, 66, 68, 69, 73 and 82. The other
group included the HPV types 6, 11, 40, 42, 54, 55, 61,
62, 64, 67, 70, 71, 72, 81, 83, 84, IS39 and CP6108.
Positive hybridization was detected by streptavidin-
horseradish peroxidase-mediated color precipitation on
the membrane at the probe array.
According to their epidemiological association with
cervical cancer and consolidated by biological studies, 12
types of HPV (HPV-16, HPV-18, HPV-31, HPV-33,
HPV-35, HPV-39, HPV-45, HPV-51, HPV-52, HPV-56,
HPV-58 and HPV-59) have now been consistently classi-
fied as hrHPV (also known as IARC class I). HPV-68 has
been classified as probable high-risk (also known as
IARC class 2A), and another seven types have been clas-
sified as possible high-risk (HPV-26, HPV-53, HPV-66,
HPV-67, HPV-70, HPV-73 and HPV-82; also known as
IARC class 2B) [14, 15].
Histopathology
The specimens were reviewed in accordance with the
World Health Organization criteria (Scully et al. 1994)
[16] and were classified as: CIN 1, CIN 2, CIN 3, inva-
sive squamous carcinoma or invasive adenocarcinoma.
Statistical analysis
A database including demographic and behavioral fac-
tors was analyzed using the SPSS statistical software
package (SPSS, Inc., Chicago, IL, USA). Crude and ad-
justed odds ratios (OR) for trends with 95 % confidence
intervals (95 % CI) were calculated and the chi-square
test was used whenever appropriate. The significance
level for the tests (p) was set at 0.05.
Results
The demographic, sexual and reproductive characteris-
tics of the study sample are shown in Table 1. The mean
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was 34 years, with 56.1 % (111/198) being < 35 years of
age and 43.9 % (87/198) being ≥ 35 years of age.
Overall, 32.3 % of the women (64/198) had their first
sexual intercourse prior to 16 years of age. Forty of the
women (20.2 %) had had a single sexual partner during
their lifetime, while 158 (79.8 %) reported having had
two or more partners over their lifetime. Most women
(167/198, 84.3 %) reported having been pregnant at least
once. Oral contraceptive use was reported by 49 women
(24.7 %). Forty-two women (21.2 %) reported smoking.
Of the women referred with abnormal cervical smears,
87 % (171/198) had an HPV infection, including 42.4 %
of women infected with HPV types 16 and 18 and
43.9 % of women infected with other HPV types.
The distribution of HPV genotypes and histological
diagnosis is shown in Table 2. The prevalence of HPV
16 and 18 in the women with a histological diagnosis ofTable 1 Demographic variables of the women enrolled in this
study
Age n %
< 35 years 111 53.1
≥ 35 years 87 43.9
Initiation of sexual activity
<16 years 64 32.3
≥16 years 134 67.7
Number of partners
1 40 20.2
≥2 158 79.8
Pregnancies
None 31 15.7
≥1 167 84.3
Oral contraceptive use
Yes 49 24.7
No 149 75.3
Smoking
Yes 42 21.2
No 156 78.8
HPV infection
Yes 171 86.4
No 27 13.6
HPV 16 and 18
Yes 84 42.4
No 87 43.9
Other HPV types
Yes 87 43.9
No 84 42.4
Total 198 100CIN 1 was 31.8 % (21/66). With respect to more severe le-
sions, HPV 16 and 18 infections were present in 61.5 % of
cases (24/39) of CIN 2, 43.2 % of cases (19/44) of CIN 3
and 88.9 % of cases (8/9) of invasive carcinoma (including
5 squamous cell carcinomas and 3 adenocarcinomas).
A significant association was found among women
who had their first sexual intercourse prior to 16 years of
age and HPV infection (OR 4.41; 95 %CI: 1.20- 19.33). In
addition, a positive association was found between a
woman having initiated her sexual life prior to 16 years
of age and infection by HPV types 16 and 18 (OR 4.68;
95 %CI: 1.20 - 21.32). The same analysis was performed
with respect to these risk factors and other types of
HPV; however, no such association was found. Further-
more, no association was found between any of the
other risk factors (such as age, number of sexual part-
ners, number of pregnancies, oral contraceptive use
and smoking) and HPV infection (Table 3).
A statistically significant association was also found
between a histological diagnosis of cervical intraepithe-
lial neoplasia (CIN) 1 or worse and women who had had
their first sexual intercourse prior to 16 years of age (OR
2.2; 95 %CI: 0.94 - 5.08). CIN 1 or worse was also signifi-
cantly associated with HPV infection (OR 2.76; 95 %CI:
1.05 - 7.19) and with HPV 16 and 18 infections (OR
3.53; 95 %CI: 1.17 - 10.67). However, no association was
found with any of the other HPV types (OR 2.25; 95
%CI 0.80 - 6.36) (Table 4).
Discussion
Age at first sexual intercourse prior to 16 years of age
was found to be significantly associated with HPV infec-
tion, particularly with high-risk oncogenic HPV 16 and
18 types, and with CIN 1 or worse in women referred
because of an abnormal cervical smear. The diagnosis of
CIN 1 or worse was also associated with HPV infection,
particularly HPV types 16 and 18.
Several studies have shown that cervical infections
occur shortly after sexual debut, emphasizing the im-
portance of sexual intercourse in transmission [17]. The
risk of infection also increases with each new sexual
partner, underscoring the ease of transmission via sexual
acts [17].
Women who begin to have sexual intercourse before
the age of 16 are more vulnerable to HPV infection be-
cause during puberty the cervix undergoes cellular
changes at the transformation zone that are known as
ectopy [18]. During ectopy, the cervical cells may not
only be more susceptible to HPV infection, but they may
also be more prone to persistent HPV infection and to
more lasting damage from an infection [19]. Almonte
et al. [20] observed that having first sexual intercourse at
an early age and having several sexual partners during a
lifetime increased the risk of having high-risk HPV (age-
Table 2 Prevalence of HPV genotypes and histological diagnosis
HPV types Negative CIN1 CIN2 CIN3 Invasive a Total
n (%) n (%) n (%) n (%) n (%) n (%)
Other HPV types 18 (45) 35 (53.0) 12 (30.8) 21(47.7) 1(11.1) 87 (43.9)
HPV 16/18- positive 12 (30) 21 (31.8) 24 (61.5) 19 (43.2) 8 (88.9) 84 (42.4)
HPV-negative 10 (25) 10 (15.2) 3 (7.7) 4 (9.1) 0 27 (13.6)
Total HPV positive 30 (75) 56 (84.8) 36 (92.3) 40 (90.9) 9 (100) 171 86.4)
Total 40 (100) 66 (100) 39 (100) 44 (100) 9 (100) 198 (100)
aInvasive carcinoma included 3 cases of adenocarcinomas. HPV: Human papillomavirus
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intercourse).
Early age at first sexual intercourse, which may be a
marker for the total number of sexual partners, is also
associated with the risk of progression of the disease
among HPV-positive individuals [21]. An active HPV in-
fection is likely to be dependent on recent sexual activ-
ity, hence acquired recently, whereas latent or persistent
infection could have been influenced by past sexual be-
havior. A greater number of lifetime sexual partners may
increase the risk of becoming infected with one or more
HPV types over time [2].Table 3 Association between HPV infection and variables associated
Risk factor OR (95 % CI)a p-value
Age
<35 years 0.86(0.35-2.10) 0.71
≥35 years
Initiation of sexual activity
<16 years 4.41(1.20-19.33) 0.01
≥16 years
Number of partners
1 0.8(0.32-1.97) 0.3
≥2
Number of partners
<3 1.21(0.5-2.95) 0.6
≥3
Pregnancies
None 0.64(0.14-2.45) 0.48
≥1
Oral contraceptive
Yes 1.1(0.38-2.93) 0.88
No
Smoking
Yes 1.6(0.50-5.99) 0.38
No
aconfidence interval. HPV: Human papillomavirus
bHPV types 16 and 18, Reference HPV-negative
cOther HPV types except HPV 16 and 18, Reference HPV 16 and 18In the present study, no association was found be-
tween the number of sexual partners and HPV infection
or lesions of CIN 1 or worse. A study conducted in Latin
America and the Caribbean showed that women tend to
remain monogamous once married or cohabiting, while
men do not [22]; therefore, a woman’s risk of contract-
ing HPV infection depends to a great extent on the sex-
ual behavior of her male partner(s).
Studies have consistently shown an increased risk of
male genital HPV positivity with sexual behavior, which
could lead to an increased risk of cervical cancer in their
female partners. More studies are needed in order towith clinical behavior
OR (95%CI)b p-value OR (95%CI)c p-value
0.87(0.33-2.29) 0.76 0.97(0.51-1.85) 0.02
4.68(1.20-21.32) 0.01 0.9(0.46-1.76) 0.7
1.2(0.37-3.88) 0.7 0.9(0.40-2.04) 0.8
1.2(0.45-3.08) 0.7 1.06(0.55-2.05) 0.85
0.7(0.15-3.32) 0.67 0.7(0.3-1.80) 0.46
1.49(0.48-4.57) 0.44 0.5(0.25-1.19) 0.09
1.8(0.50-6.97) 0.32 0.83(0.38-1.82) 0.62
Table 4 Risk factors and association with a histological
diagnosis of CIN 1 or worse
Risk factor OR (95%CI) p-value
Age
<35 years 1.19
(0.59-2.40)
0.3
≥35 years
Initiation of sexual activity
<16 years 2.2
(0.94-5.08)
0.03
≥16 years
Number of partners
1 0.7
(0.36-1.54)
0.2
≥2
Number of partners
<3 1.21
(0.5-2.95)
0.6
≥3
Pregnancies
None 0.46
(0.18-1.77)
0.06
≥1
Oral contraceptive use
Yes 1.2 (0.5-2.62) 0.3
No
Smoking
Yes 0.6 (0.28-
1.22)
0.11
No
HPV infectiona
Yes 2.76
(1.05-7.19)
0.03
No
HPV 16 and 18 infection
Yes
No 3.53
(1.17-10.67)
0.02
Infection by HPV types other than HPV 16 and
18
Yes
No 2.25
(0.80-6.36)
0.08
aReference HPV-negative, CIN: Cervical intraepithelial neoplasia
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fection in males and its relationship with the risk of ac-
quiring HPV and the development of cervical cancer in
women [8].
Cervical neoplasia associated with infection by individ-
ual HPV types has been evaluated up to a certain pointand there are indications that the specific types lead to
different risks with respect to persistence and progres-
sion [23]. HPV types 16 and 18 may account for around
70 % of all cervical cancer. HPV type 16 has the highest
oncogenic potential, followed by type 18 as the next
most virulent [1].
Significant associations were found between women
who had their first sexual intercourse prior to 16 years
of age and HPV 16 and HPV 18 infections and lesions of
CIN 1 or worse. HPV 16 and 18 are the types most com-
monly associated with cervical cancer [11]. A recent re-
port found a 10-year increased risk of cervical precancer
and cancer for HPV 18 that was similar in magnitude to
that found for HPV 16 [24].
Knowledge on the incidence of the different HPV ge-
notypes is needed in order to focus appropriately on pre-
ventive, diagnostic and therapeutic measures. Mazarico
et al. [25] showed that HPV-positive patients were youn-
ger (mean age 32.3 years) than HPV-negative women
(39.8 years). Baandrup et al. [26] showed that HPV 16-
associated CIN 3 lesions occur at a significantly younger
age than lesions associated with other high-risk HPV
infections.
This study showed that women who began to have
sexual intercourse before the age of 16 had a 2.2-fold
higher risk of developing CIN 1 lesions or worse. These
data are in agreement with the findings of Flores et al.
[27] who reported a two-fold higher risk of high grade
CIN and cervical cancer in women who had their first
sexual intercourse prior to 16 years of age. According to
those authors, this increased risk may be attributable to
age at first sexual intercourse since this event may be a
proxy for the time of first HPV infection. Women who
had sexual intercourse for the first time at a younger age
may have been exposed to a persistent HPV infection
for longer periods compared to women who began to
have sex at a later age [28].
In relation to risk factors such as high parity, the use
of oral contraceptives, number of pregnancies and smok-
ing, no statistically significant association was found
with HPV infection or lesions of CIN 1 or worse. Other
investigators have also reported a negative association
between HPV infection and these risk factors [11]. On
the other hand, some studies have reported that the
number of sexual partners, pregnancy and past or
current smoking were all factors predictive of HPV in-
fection [28–30].
In fact, the use of oral contraceptives and smoking
were the two principal factors found to accelerate mat-
uration and are also known to be important risk factors
for cervical neoplasia [7, 31]. One limitation of the
present study was the behavior profile of the women en-
rolled. The majority of women were not present or past
smokers and this limitation precluded the possibility of
Ribeiro et al. Infectious Agents and Cancer  (2015) 10:16 Page 6 of 7carrying out any assessment on the effect of smoking on
HPV acquisition.
As cervical cancer precursor lesions are the target of
cervical cancer screening programs, it is important to
improve understanding of the association between age
and precancerous lesions of the cervix according to
HPV type [26].
Conclusions
Early events that can modify the carcinogenic potential
of HPV infection include early age at first intercourse,
which is a possible proxy of longer duration of persistent
HPV infection. Understanding the epidemiology of geni-
tal HPV infection is important for the development of
preventive actions against this infection and against
HPV-related neoplasia.
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